Caetani Rejane, Wiechmann Susana L, Brancher Jacques D, Oliveira Vitor H F, Deminice Rafael
Health Sciences Center, State University of Londrina, Londrina, Brazil.
Department of Clinical Medicine, State University of Londrina, Londrina, Brazil.
South Afr J HIV Med. 2025 Jan 31;26(1):1646. doi: 10.4102/sajhivmed.v26i1.1646. eCollection 2025.
The success of HIV treatment hinges on consistent adherence to antiretroviral therapy (ART).
To conduct a longitudinal pilot study to assess the feasibility, acceptability and effectiveness of a mobile app to improve ART adherence.
This study included adults living with HIV and using ART, who were allocated into two groups according to their willingness to use the app: users of the mobile application for ART management (Mobile) and non-users (Control). The application was developed by the researchers, and uses an alarm system to record ART use. Adherence was also assessed using the '' (CEAT-VIH) and the Multi-Method Tool questionnaire. Another questionnaire was administered to application users to assess acceptability. After 90 days, all the questionnaires were reapplied.
A significant difference in adherence was observed between the Mobile and Control groups ( = 0.04), but there was no significant difference in time ( = 0.2) or interaction ( = 0.5).
The application was not effective in improving ART adherence and showed low viability, but was considered acceptable among the participants.
艾滋病病毒治疗的成功取决于对抗逆转录病毒疗法(ART)的持续坚持。
开展一项纵向试点研究,以评估一款用于提高ART依从性的移动应用程序的可行性、可接受性和有效性。
本研究纳入了正在接受ART治疗的成年艾滋病病毒感染者,根据他们使用该应用程序的意愿将其分为两组:ART管理移动应用程序用户(移动组)和非用户(对照组)。该应用程序由研究人员开发,使用警报系统记录ART使用情况。还使用“艾滋病病毒治疗依从性综合评估工具”(CEAT-VIH)和多方法工具问卷评估依从性。向应用程序用户发放了另一份问卷以评估可接受性。90天后,重新发放所有问卷。
移动组和对照组在依从性方面存在显著差异(P = 0.04),但在时间方面(P = 0.2)或交互作用方面(P = 0.5)无显著差异。
该应用程序在提高ART依从性方面无效,且可行性较低,但在参与者中被认为是可接受的。